Literature DB >> 11356101

Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers.

S Girault1, P Grellier, A Berecibar, L Maes, P Lemière, E Mouray, E Davioud-Charvet, C Sergheraert.   

Abstract

Bisquinoline heteroalkanediamines were structurally modified in order to study the effects of enhanced bulkiness and rigidity on both their activity on strains of Plasmodium falciparum expressing different degrees of chloroquine (CQ) resistance and their cytotoxicity toward mammalian cells. While cyclization yielded molecules of greater rigidity that were not more active than their linear counterparts, they were characterized by an absence of cytotoxicity. Alternatively, dimerization of these compounds led to tetraquinolines that are very potent for CQ-resistant strains and noncytotoxic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356101     DOI: 10.1021/jm001096a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines).

Authors:  Kirandeep Kaur; Meenakshi Jain; Shabana I Khan; Melissa R Jacob; Babu L Tekwani; Savita Singh; Prati Pal Singh; Rahul Jain
Journal:  Bioorg Med Chem       Date:  2010-11-25       Impact factor: 3.641

2.  Potent Antimalarial Activity of Two Arenes Linked with Triamine Designed To Have Multiple Interactions with Heme.

Authors:  Yosuke Sakata; Kosuke Yabunaka; Yuko Kobayashi; Hirohisa Omiya; Naoki Umezawa; Hye-Sook Kim; Yusuke Wataya; Yoshimi Tomita; Yosuke Hisamatsu; Nobuki Kato; Hirokazu Yagi; Tadashi Satoh; Koichi Kato; Haruto Ishikawa; Tsunehiko Higuchi
Journal:  ACS Med Chem Lett       Date:  2018-09-24       Impact factor: 4.345

3.  Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency.

Authors:  Quentin McAfee; Zhihui Zhang; Arabinda Samanta; Samuel M Levi; Xiao-Hong Ma; Shengfu Piao; John P Lynch; Takeshi Uehara; Antonia R Sepulveda; Lisa E Davis; Jeffrey D Winkler; Ravi K Amaravadi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

4.  Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.

Authors:  Anna Caroline Campos Aguiar; Raquel de Meneses Santos; Flávio Júnior Barbosa Figueiredo; Wilian Augusto Cortopassi; André Silva Pimentel; Tanos Celmar Costa França; Mario Roberto Meneghetti; Antoniana Ursine Krettli
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

5.  Anticancer properties of bisaminoquinolines with modified linkers.

Authors:  Yuanhao Wang; Vaibhav Jain; Amanda Versace; Monika Bhardwaj; Mary Ann S Crissey; Ravi K Amaravadi; Jeffrey D Winkler
Journal:  Bioorg Med Chem Lett       Date:  2021-07-21       Impact factor: 2.940

6.  Synthesis and antiplasmodial activity of betulinic acid and ursolic acid analogues.

Authors:  Adrine M Innocente; Gloria N S Silva; Laura Nogueira Cruz; Miriam S Moraes; Myna Nakabashi; Pascal Sonnet; Grace Gosmann; Célia R S Garcia; Simone C B Gnoatto
Journal:  Molecules       Date:  2012-10-12       Impact factor: 4.411

7.  Palladium-catalyzed amination of dichloroquinolines with adamantane-containing amines.

Authors:  Anton S Abel; Alexei D Averin; Olga A Maloshitskaya; Evgenii N Savelyev; Boris S Orlinson; Ivan A Novakov; Irina P Beletskaya
Journal:  Molecules       Date:  2013-02-06       Impact factor: 4.411

8.  Unsymmetrical Bisquinolines with High Potency against P. falciparum Malaria.

Authors:  Katherine M Liebman; Steven J Burgess; Bornface Gunsaru; Jane X Kelly; Yuexin Li; Westin Morrill; Michael C Liebman; David H Peyton
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.